Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor of Orthopaedic and Tropical Surgery and Consultant Orthopaedic and Spine Surgeon Chris Lavy has been awarded a prestigious honorary fellowship by the British Orthopaedic Association (BOA).

Photo of Chris Lavy

An Honorary Fellowship is the highest honour that the BOA offer, and is awarded to individuals who have made outstanding contributions to trauma and orthopaedics.

Professor Lavy's clinical interests include surgery of the spine, hip and knee, and his research interests focus on surgery in Africa and the Tropics. He leads the NDORMS Lavy Global Surgery group which is deeply involved in research, teaching and training to strengthen surgical care and training capacity in Africa. This includes SURG-AFRICA, which is focused on scaling up safe surgery in district hospitals to make it accessible to otherwise neglected rural populations, and clubfoot training and research to help to improve treatment for children born with clubfoot in Africa.

One of his newest emerging areas of research is into treatments that could improve the recovery rate from spinal cord injuries.

Candidates for Honorary Fellowships are considered annually by a Board comprising the last five BOA Presidents and usually presented to recipients by the President at the annual BOA Congress.

Due to the coronavirus pandemic, Prof Lavy was presented with the award virtually at this year's BOA conference, and will receive the award in person at the BOA Congress in Aberdeen next September.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.